In Phase I / Bioequivalence

PharmaNet offers a comprehensive range of clinical development and consulting services for early stage programs, including Phase I and bioequivalence studies. PharmaNet conducts early stage programs for international sponsors through our global network of resources.

Quality Assurance

Working with leaders in the field and global regulatory bodies, our Quality Assurance Group has developed strict quality assurance controls covering every step in the process.

 

All departments, including data processing and report writing, comply with the standards of Good Clinical Practices (GCPs) and Good Laboratory Practices (GLPs), in accordance with current SOPs. Study data and reports are 100% audited before receiving our Quality Assurance seal.

 

An independent ethics committee reviews study protocols and informed consent forms. This committee complies with current regulations and ensures a written response within 72 hours of the review. Weekly meetings allow greater flexibility in reviewing and approving study documents.

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390